Literature DB >> 7630346

Detection of HTLV-I provirus by in situ polymerase chain reaction in mononuclear inflammatory cells in skeletal muscle of viral carriers with polymyositis.

I Higuchi1, K Hashimoto, N Kashio, S Izumo, M Inose, K Izumi, R Ohkubo, M Nakagawa, K Arimura, M Osame.   

Abstract

We tested for HTLV-I proviral DNA in skeletal muscle from patients with polymyositis infected with HTLV-I using the in situ polymerase chain reaction. We found the HTLV-I provirus in some of the CD4-positive cells in HTLV-I-positive polymyositis cases but not in HTLV-I-negative polymyositis ones. We could not detect HTLV-I within the muscle fibers. We suggest that HTLV-I-associated polymyositis is not due to direct, persistent infection of the muscle fiber by the virus, but to a T-cell-mediated immunological process triggered by the HTLV-I-infected cells.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7630346     DOI: 10.1002/mus.880180809

Source DB:  PubMed          Journal:  Muscle Nerve        ISSN: 0148-639X            Impact factor:   3.217


  6 in total

Review 1.  Neuroimmunity of HTLV-I Infection.

Authors:  Eiji Matsuura; Yoshihisa Yamano; Steven Jacobson
Journal:  J Neuroimmune Pharmacol       Date:  2010-05-02       Impact factor: 4.147

2.  Muscle wasting induced by HTLV-1 tax-1 protein: an in vitro and in vivo study.

Authors:  Simona Ozden; Vincent Mouly; Marie-Christine Prevost; Antoine Gessain; Gillian Butler-Browne; Pierre-Emmanuel Ceccaldi
Journal:  Am J Pathol       Date:  2005-12       Impact factor: 4.307

3.  Peripheral neuropathy in HTLV-I infected individuals without tropical spastic paraparesis/HTLV-I-associated myelopathy.

Authors:  Ana C C Leite; Marcus Tulius T Silva; Alexandre H Alamy; Cristiane R A Afonso; Marco A D Lima; Maria J Andrada-Serpa; Osvaldo J M Nascimento; Abelardo Q-C Araújo
Journal:  J Neurol       Date:  2004-07       Impact factor: 4.849

4.  Direct evidence for a chronic CD8+-T-cell-mediated immune reaction to tax within the muscle of a human T-cell leukemia/lymphoma virus type 1-infected patient with sporadic inclusion body myositis.

Authors:  Simona Ozden; Madeleine Cochet; Jacqueline Mikol; Antonio Teixeira; Antoine Gessain; Claudine Pique
Journal:  J Virol       Date:  2004-10       Impact factor: 5.103

Review 5.  Treatment of HTLV-I-associated myelopathy/tropical spastic paraparesis: toward rational targeted therapy.

Authors:  Unsong Oh; Steven Jacobson
Journal:  Neurol Clin       Date:  2008-08       Impact factor: 3.806

6.  Clinical presentation of axial myopathy in two siblings with HTLV-1 associated myelopathy/tropical spastic paraparesis (HAM/TSP).

Authors:  Eiji Matsuura; Akiko Yoshimura; Satoshi Nozuma; Itsuro Higuchi; Ryuji Kubota; Hiroshi Takashima
Journal:  BMC Neurol       Date:  2015-02-28       Impact factor: 2.474

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.